Biotransformation of Lithocholic Acid by Rat Hepatic Microsomes: Metabolite Analysis by Liquid Chromatography/Mass Spectrometry
- 1 February 2008
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 36 (2) , 442-451
- https://doi.org/10.1124/dmd.107.017533
Abstract
Lithocholic acid is a lipid-soluble hepatotoxic bile acid that accumulates in the liver during cholestasis. A potential detoxification pathway for lithocholic acid involves hydroxylation by hepatic cytochrome P450 (P450) enzymes. The purpose of the present study was to identify the hepatic microsomal metabolites of lithocholic acid by liquid chromatography/mass spectrometry and to determine the P450 enzymes involved. Incubation of lithocholic acid with rat hepatic microsomes and NADPH produced murideoxycholic acid (MDCA), isolithocholic acid (ILCA), and 3-keto-5β-cholanic acid (3KCA) as major metabolites and 6-ketolithocholic acid and ursodeoxycholic acid as minor metabolites. Experiments with hepatic microsomes prepared from rats pretreated with P450 inducers and with inhibitory antibodies indicated that CYP2C and CYP3A enzymes contribute to microsomal MDCA formation. Results obtained with a panel of recombinant P450 enzymes and CYP2D6 antiserum showed that CYP2D1 can also catalyze MDCA formation. Similar experimental evidence revealed that formation of 3KCA was mediated primarily by CYP3A enzymes. ILCA formation appeared to be catalyzed by a distinct pathway mediated largely by microsomal non-P450 enzymes. Based on the results obtained using lithocholic acid and 3KCA as substrates, a mechanism for the formation of ILCA involving a geminal diol intermediate is outlined. In conclusion, lithocholic acid was extensively metabolized by multiple P450 enzymes with the predominant biotransformation pathway being hydroxylation at the 6β-position. This study provides an insight into possible routes of detoxification of lithocholic acid.This publication has 35 references indexed in Scilit:
- Novel pathways of bile acid metabolism involving CYP3A4Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2004
- The Bile Acid Nuclear Receptor FXR and the Bile Acid Binding Protein IBABP Are Differently Expressed in Colon CancerDigestive Diseases and Sciences, 2004
- Activators of the Rat Pregnane X Receptor Differentially Modulate Hepatic and Intestinal Gene ExpressionMolecular Pharmacology, 2004
- Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug HepatotoxicityDrug Metabolism Reviews, 2004
- Cholestatic liver disease: pathophysiology and therapeutic optionsLiver International, 2002
- The Continuing Importance of Bile Acids in Liver and Intestinal DiseaseArchives of internal medicine (1960), 1999
- 6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- Hepatic levels of bile acids in end-stage chronic cholestatic liver diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis: Evaluation in rats by combined radiochromatography and gas-liquid chromatograpry-mass spectrometryBiochemical Pharmacology, 1994
- Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbitDigestive Diseases and Sciences, 1974